The One Big Beautiful Bill (OBBB) rolled back a costly tax change by restoring the immediate deductibility of domestic R&D expenses under IRC Section 174. This long-awaited fix can reduce taxable income, improve cash flow and strengthen innovation budgets for companies that invest in U.S.-based research and development.
In this webinar, Wipfli tax specialists explain how the OBBB impacts manufacturers, technology firms, life sciences companies and other R&D-intensive businesses. We cover:
- How the new rules affect current and future filings.
- Ways to maximize your R&D tax credit.
- Strategic planning moves to capture eligible benefits.
Turn recent tax changes into a competitive advantage. Watch the replay to learn how.